Program re-accredited until 2031

Translate to Spanish or other 102 languages!

The Commission on Accreditation for Respiratory Care (CoARC) has reaffirmed South Texas College’s Respiratory Therapy Program accreditation for the next 10 years. Courtesy Image
The Commission on Accreditation for Respiratory Care (CoARC) has reaffirmed South Texas College’s Respiratory Therapy Program accreditation for the next 10 years. Courtesy Image

Mega Doctor News

- Advertisement -

MCALLEN, Texas – The Commission on Accreditation for Respiratory Care (CoARC) has reaffirmed South Texas College’s Respiratory Therapy Program accreditation for the next 10 years. 

Following a thorough review, CoARC determined that Respiratory Therapy met all national established accreditation standards and commended the program for its continuous quality in education. 

The reaffirmation was essential for the college so it can continue awarding a Respiratory Therapy Associate of Applied Science to students who have successfully completed the program. 

- Advertisement -

Accreditation as outlined by CoARC provides assurance to prospective students, their families and the general public that the program meets minimum requirements and that there are reasonable grounds to believe the program will continue to meet those standards in the future.

“Thanks to the leadership of Mr. Gabriel Pena, Program Chair and the dedication of his faculty and staff, we will continue to ensure our ability to educate and credential our Respiratory Therapy students, and ensure that these credentials are recognized and valued,” said STC Dean of Nursing and Allied Health Dr. Jayson Valerio. “Accreditation is the most vital guarantee of South Texas College’s quality, rigor, and integrity to our stakeholders.” 

At its December 2021 meeting, CoARC voted to reaffirm Continuing Accreditation to the AAS Entry in Respiratory Care Professional Practice Program at South Texas College. 

The recent accreditation review conducted by CoARC recognizes the program’s compliance with nationally established accreditation standards. The next comprehensive evaluation of the program, including an onsite review, is scheduled to occur no later than 2031.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

DHR Health to Host 13th Annual Circle of Care Caregivers Conference

DHR Health Rehabilitation Hospital will host its 13th Annual Circle of Care Caregivers Conference on Saturday, November 7, 2026, at the Edinburg Conference Center at Renaissance, offering educational presentations and resources for individuals caring for family members and loved ones.

HHS Opens $1 Million Funding Opportunity to Strengthen Women’s Preventive Care

The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), announced a Notice of Funding Opportunity (NOFO) for the Women’s Initiative for Screening and Health (WISH) program.
- Advertisement -